Results 11 to 20 of about 1,810 (164)

Etymologia: Oropouche Virus [PDF]

open access: yesEmerging Infectious Diseases, 2018
Ronnie Henry, Frederck A. Murphy
doaj   +2 more sources

Charting the Proteins of Oropouche Virus. [PDF]

open access: yesViruses
Abstract The Oropouche virus (OROV) is responsible for the disease Oropouche fever, also known as sloth fever. This virus is currently endemic to the Americas and is transmitted primarily through midges and mosquitoes. Recently, an increase in cases has been noted among American and European tourists visiting Cuba, likely due to environmental ...
Thomas S.
europepmc   +4 more sources

RASTREIO DO VÍRUS OROPOUCHE NO ESTADO DE GOIÁS

open access: yesBrazilian Journal of Infectious Diseases, 2022
Introdução: São conhecidos como arbovírus, os patógenos capazes de infectar vertebrados e invertebrados, através da picada de um vetor artrópode (Casseb et al., 2013).
Diego Michel Fernandes da Silva   +5 more
doaj   +1 more source

Reemergence of Oropouche Fever, Northern Brazil

open access: yesEmerging Infectious Diseases, 2007
Oropouche fever has reemerged in Parauapebas and Porto de Moz municipalities, Pará State, Brazil. Serologic analysis (immunoglobulin M–ELISA) and virus isolation confirmed Oropouche virus (OROV) in both municipalities.
Raimunda do Socorro da Silva Azevedo   +9 more
doaj   +1 more source

Oropouche virus infection in patients with acute febrile syndrome: Is a predictive model based solely on signs and symptoms useful?

open access: yesPLoS ONE, 2022
BackgroundOropouche fever is an infectious disease caused by the Oropouche virus (OROV). The diagnosis and prediction of the clinical picture continue to be a great challenge for clinicians who manage patients with acute febrile syndrome.
Hilda V Durango-Chavez   +6 more
doaj   +1 more source

Preclinical Models of Oropouche Virus Infection and Disease. [PDF]

open access: yesPathogens
Oropouche virus (OROV) is an emerging and underreported arbovirus with dengue-like symptoms confounding diagnosis. OROV is also neuroinvasive, with a small number of cases presenting severe neurological symptoms. There have been recently reported deaths from confirmed cases of OROV and reported instances of vertical transmission from mother to foetus ...
Morley D, Kennedy E, Dowall S.
europepmc   +3 more sources

Iquitos virus: a novel reassortant Orthobunyavirus associated with human illness in Peru. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2011
Oropouche (ORO) virus, a member of the Simbu serogroup, is one of the few human pathogens in the Orthobunyavirus genus in the family Bunyaviridae. Genetic analyses of ORO-like strains from Iquitos, Peru, identified a novel reassortant containing the S ...
Patricia V Aguilar   +11 more
doaj   +1 more source

Oropouche virus – another antecedent event for Guillain–Barré syndrome?

open access: yesRevista Panamericana de Salud Pública
In May 2024, the Pan American Health Organization issued alerts of increased numbers of cases of Oropouche fever in non-Amazonian regions in Latin America. Following this, an association between Oropouche fever and Guillain–Barré syndrome was reported in
Alina González-Quevedo   +2 more
doaj   +1 more source

Entre o desconhecido e o emergente: mapeando os vírus Oropouche e Mayaro no Brasil [PDF]

open access: yesCadernos de Saúde Pública
As arboviroses são doenças infecciosas causadas por vírus transmitidos por artrópodes. Antes da introdução dos vírus Chikungunya e Zika no Brasil, o vírus Oropouche (OROV) era o segundo arbovírus mais prevalente em humanos, atrás apenas do vírus Dengue ...
Gabriele Nascimento de Oliveira   +5 more
doaj   +2 more sources

Oropouche Virus: An Overview of the Current Status of Diagnostics. [PDF]

open access: yesViruses
The Orthobunyavirus Oropouche (OROV) has become an urgent public health threat in Central and South America, as well as in other countries worldwide. Since its initial identification, there have been over 30 outbreaks, with the largest reported in late 2024 in Brazil.
Lapa D   +4 more
europepmc   +4 more sources

Home - About - Disclaimer - Privacy